More evidence is needed in the antibiotic treatment of Pseudomonas aeruginosa colonisation [7]

Archives of Disease in Childhood

Volumn 90, Issue 11, 2005, Pages 1204-

  Marchetti, F ^a   Bua, J ^a  

^a Institute of Child Health   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; COLISTIN; TOBRAMYCIN;

AEROSOL; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; COHORT ANALYSIS; CYSTIC FIBROSIS; EVIDENCE BASED MEDICINE; GRAM NEGATIVE INFECTION; HUMAN; LETTER; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; HUMANS; OPPORTUNISTIC INFECTIONS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 27644516754     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2005.081034     Document Type: Letter

References (6)

1. Smyth RL. Diagnosis and management of cystic fibrosis. Arch Dis Child Ed Pract 2005;90:ep1-ep6.
2. Valerius N, Koch C, Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 1991;338:725-6.
3. Marchetti F, Giglio L, Candusso M, et al. Early antibiotic treatment of pseudomonas aeruginosa colonisation in cystic fibrosis: a critical review of the literature. Eur J Clin Pharmacol 2004;60:67-74.
4. Wiesemann HG, Steinkamp G, Ratjen F, et al. Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis. Pediatr Pulmonol 1998;25:88-92.
5. Gibson RL, Emerson J, McNamara S, et al. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am J Respir Crit Care Med 2003;167:841-9.
6. Ramsey BW, Boat TF. Outcome measures for clinical trials in cystic fibrosis. J Pediatr 1994;124:177-92.